ARTICLE | Company News
Edge Therapeutics, SurModics deal
November 15, 2010 8:00 AM UTC
SurModics granted Edge Therapeutics an exclusive, worldwide license to use SurModics' biodegradable microparticles drug delivery system to develop and commercialize NimoGel ( EG-1961) to treat delaye...